2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is a toxic agent and has disruptive effects on reproductive tissues in females. TCDD disrupts the hormonal regulation of the body and decreases the production of melatonin. In this study, we investigated the protective effects of melatonin supplements against the toxic effects of TCDD on ovaries of female rats. TCDD caused a significant decrease in the average number of corpora lutea and follicles per tissue section (2.1 ± 0.7; 2.3 ± 0.8, respectively), whereas these numbers were maintained in the melatonin supplemented group (5.0 ± 0.8; 5.1 ± 0.8, respectively) and were similar to the control group (5.3 ± 1.0; 5.9 ± 0.9, respectively). Electron microscopic analysis showed that the disruption of ultrastructure components such as cell membrane and organelles due to TCDD exposure was inhibited by melatonin supplements. This study suggested that melatonin has a protective and a possible ameliorative effect over histopathological damage of rat ovaries exposed to TCDD.
ArendtJSkeneDJ (2003) Melatonin as a chronobiotic. Sleep Medicine Reviews9: 25–39.
2.
AylwardLLBrunetRCCarrierG. (2005) Concentration-dependent TCDD elimination kinetics in humans: toxicokinetic modeling for moderately to highly exposed adults from Seveso, Italy, and Vienna, Austria, and impact on dose estimates for the NIOSH cohort. Journal of Exposure Analysis and Environmental Epidemiology15: 51–65.
3.
BaldridgeMGMarksGTRawlinsRG. (2015) Very low-dose (femtomolar) 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) disrupts steroidogenic enzyme mRNAs and steroid secretion by human luteinizing granulosa cells. Reproductive Toxicology52: 57–61.
4.
BirnbaumLSFentonSE (2003) Cancer and developmental exposure to endocrine disruptors. Environmental Health Perspectives111: 389–394.
5.
ChangGKSeungHLEuiKK (2007) Endocrine disruptors. Journal of Korean Medical Association50(4): 359–368.
6.
ColePTrichopoulosDPastidesH. (2003) Dioxin and cancer: a critical review. Regulatory Toxicology and Pharmacology38: 378–388.
7.
CummingsAMHedgeJMBirnbaumLS (1999) Effect of prenatal exposure to TCDD on the promotion of endometriotic lesion growth by TCDD in adult female rats and mice. Toxicological Sciences52(1): 45–49.
8.
HardelandRPandi-PerumalSRCardinaliP (2006) Melatonin. The International Journal of Biochemistry & Cell Biology38(3): 313–316.
9.
HeimlerITrewinALChaffinCL. (1998) Modulation of ovarian follicle maturation and effects on apoptotic cell death in Holtzman rats exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in utero and lactationally. Reproductive Toxicology12(1): 69–73.
10.
HutzRJ (1999) Reproductive endocrine disruption by environmental xenobiotics that modulate the estrogen-signaling pathway, particularly by tetrachlorodibenzo-p-dioxin (TCDD). Journal of Reproduction and Development45: 1–12.
11.
KakeyamaMTohyamaC (2003) Developmental neurotoxicity of dioxin and its related compounds. Industrial Health41: 215–230.
12.
KangCGLeeSHKimEK (2007) Endocrine Disruptors. Journal of the Korean Medical Association50(4): 359–368.
13.
LiXJohnsonDCRozmanKK (1995) Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on estrous cyclicity and ovulation in female Sprague-Dawley rats. Toxicology Letters78: 219–222.
14.
LindenJPohjanvirtaRRahkoT. (1991) TCDD decreases rapidly and persistently serum melatonin concentration without morphologically affecting the pineal gland in TCDD-resistant Han/Wistar rats. Pharmacology and Toxicology69: 427–432.
15.
McLachlanJAKorachKS(1995) Estrogens in the environment, III: Global health implications. In: BarneySPSchroederJC (eds) Symposium on estrogens in the environment, Vol. 4. Washington, DC: Environmental Health Perspectives, 1–178.
16.
MitrouPIDimitriadisGRaptisSA (2001) Toxic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds. European Journal of Internal Medicine12: 406–411.
17.
PohjanvirtaRJarmoLVakkurO. (1996) Mechanism by which 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) reduces circulating melatonin levels in the rat. Toxicology107: 85–97.
18.
PolandAKnutsonJC (1982) 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annual Review of Pharmacology and Toxicology22: 517–554.
19.
ProoijeAWaalkens-BerendsenDWijnandsM (1994) Oral two-generation reproduction study with PCBs in rats. TNO-Report92: 503.
20.
RobyKF (2000) Alterations in follicle development, steroidogenesis, and gonadotropin receptor binding in a model of ovulatory blockade. Endocrinology142: 2328–2335.
21.
ShiverickKMutherT (1982) Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on serum concentrations and the uterotrophic action of exogenous estrone in rats. Toxicology and Applied Pharmacology65: 170–176.
22.
TuomistoJTPohjanvirtaRUnkilaM. (1999) TCDD-induced anorexia and wasting syndrome in rats: effects of diet-induced obesity and nutrition. Pharmacology Biochemistry and Behavior62(4): 735–742.
23.
WolfCJOstbyJSGrayLE (1999) Gestational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) severely alters reproductive function of female hamster offspring. Toxicological Sciences51: 259–264.
24.
WangJLiuXLiT. (2011) Increased hepatic Igf2 gene expression involves C/EBPβ in TCDD-induced teratogenesis in rats. Reproductive Toxicology32: 313–321.
25.
YeleswaramKMcLaughlinLGKnipeJO. (1997) Pharmacokinetics and oral bioavailability of exogenous melatonin in preclinical animal models and clinical implications. Journal of Pineal Research22(1): 45–51.
26.
YoshizawaKHeatherlyAMalarkeyDE. (2007) A critical comparison of murine pathology and epidemiological data of TCDD, PCB126, and PeCDF. Toxicologic Pathology35: 865–879.
27.
ZetnerDAndersenLPHRosenbergJ (2016) Pharmacokinetics of alternative administration routes of melatonin: a systematic review. Drug Research66: 169–173.
